Home LiteratureArticle Details
PMID: 8756633 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.

Molecular and cellular biology ·Vol. 16 ·No. 9 ·1996-09-00 ·Pages 4754-64

Jones RM, Branda J, Johnston KA, Polymenis M, Gadd M, Rustgi A, Callanan L, Schmidt EV

Abstract

The mRNA cap-binding protein (eukaryotic initiation factor 4E [eIF4E]) binds the m7 GpppN cap on mRNA, thereby initiating translation. eIF4E is essential and rate limiting for protein synthesis. Overexpression of eIF4E transforms cells, and mutations in eIF4E arrest cells in G, in cdc33 mutants. In this work, we identified the promoter region of the gene encoding eIF4E, because we previously identified eIF4E as a potential myc-regulated gene. In support of our previous data, a minimal, functional, 403-nucleotide promoter region of eIF4E was found to contain CACGTG E box repeats, and this core eIF4E promoter was myc responsive in cotransfections with c-myc. A direct role for myc in activating the eIF4E promoter was demonstrated by cotransfections with two dominant negative mutants of c-myc (MycdeltaTAD and MycdeltaBR) which equally suppressed promoter function. Furthermore, electrophoretic mobility shift assays demonstrated quantitative binding to the E box motifs that correlated with myc levels in the electrophoretic mobility shift assay extracts; supershift assays demonstrated max and USF binding to the same motif. cis mutations in the core or flank of the eIF4E E box simultaneously altered myc-max and USF binding and inactivated the promoter. Indeed, mutations of this E box inactivated the promoter in all cells tested, suggesting it is essential for expression of eIF4E. Furthermore, the GGCCACGTG(A/T)C(C/G) sequence is shared with other in vivo targets for c-myc, but unlike other targets, it is located in the immediate promoter region. Its critical function in the eIF4E promoter coupled with the known functional significance of eIF4E in growth regulation makes it a particularly interesting target for c-myc regulation.

MeSH Terms
Animals Base Sequence Cell Line Chlorocebus aethiops DNA-Binding Proteins Eukaryotic Initiation Factor-4E Fibroblasts Gene Expression Regulation HeLa Cells Humans Models, Genetic Molecular Sequence Data Mutagenesis, Site-Directed Peptide Initiation Factors/biosynthesis,genetics Promoter Regions, Genetic/genetics Protein Biosynthesis/physiology Proto-Oncogene Proteins c-myc/physiology RNA Caps/metabolism Rats Recombinant Fusion Proteins/biosynthesis Repetitive Sequences, Nucleic Acid Transcription Factors/metabolism Transcription, Genetic Transfection Upstream Stimulatory Factors
Chemicals
DNA-Binding Proteins Eukaryotic Initiation Factor-4E Peptide Initiation Factors Proto-Oncogene Proteins c-myc RNA Caps Recombinant Fusion Proteins Transcription Factors USF1 protein, human Upstream Stimulatory Factors Usf1 protein, rat
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Jones R M
Massachusetts General Hospital Cancer Center, Charlestown, 02129, USA.
Branda J
Johnston K A
Polymenis M
Gadd M
Rustgi A
Callanan L
Schmidt E V
References (71)
71 references, click to expand
  1. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence.
    Genes Dev. 1992 Dec;6(12B):2513-23 PMID: 1340466
  2. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E.
    Mol Cell Biol. 1993 Dec;13(12):7358-63 PMID: 8246956
  3. Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.
    EMBO J. 1993 Dec 15;12(13):5075-82 PMID: 8262050
  4. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
    EMBO J. 1993 Dec 15;12(13):5083-7 PMID: 8262051
  5. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae.
    J Biol Chem. 1994 Feb 11;269(6):3934-40 PMID: 8307948
  6. Is hypusine essential for eukaryotic cell proliferation?
    Trends Biochem Sci. 1993 Dec;18(12):475-9 PMID: 8108861
  7. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells.
    Nucleic Acids Res. 1994 Feb 11;22(3):427-33 PMID: 8127680
  8. Ras mediates translation initiation factor 4E-induced malignant transformation.
    Genes Dev. 1992 Sep;6(9):1631-42 PMID: 1516827
  9. mRNAs containing extensive secondary structure in their 5' non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E.
    EMBO J. 1992 Nov;11(11):4153-8 PMID: 1396596
  10. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
    Nature. 1992 Oct 1;359(6394):423-6 PMID: 1406955
  11. Myc and Max proteins possess distinct transcriptional activities.
    Nature. 1992 Oct 1;359(6394):426-9 PMID: 1406956
  12. Ornithine decarboxylase activity is critical for cell transformation.
    Nature. 1992 Nov 26;360(6402):355-8 PMID: 1280331
  13. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Cell. 1993 Jan 29;72(2):233-45 PMID: 8425220
  14. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters.
    EMBO J. 1993 Feb;12(2):501-11 PMID: 8440240
  15. An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
    Mol Cell Biol. 1990 Nov;10(11):5914-20 PMID: 2233723
  16. Sequence-specific DNA binding by the c-Myc protein.
    Science. 1990 Nov 23;250(4984):1149-51 PMID: 2251503
  17. The Xenopus B1 factor is closely related to the mammalian activator USF and is implicated in the developmental regulation of TFIIIA gene expression.
    Mol Cell Biol. 1991 Jan;11(1):412-24 PMID: 1986236
  18. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.
    Science. 1991 Jan 11;251(4990):186-9 PMID: 1987636
  19. Oncogenic conversion by regulatory changes in transcription factors.
    Cell. 1991 Jan 25;64(2):303-12 PMID: 1988149
  20. The MYC protein activates transcription of the alpha-prothymosin gene.
    EMBO J. 1991 Jan;10(1):133-41 PMID: 1989881
  21. Translation factors as effectors of cell growth and tumorigenesis.
    Curr Opin Cell Biol. 1993 Dec;5(6):955-60 PMID: 7907492
  22. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc.
    Mol Cell Biol. 1994 Jun;14(6):3853-62 PMID: 8196628
  23. Induction of mesoderm in Xenopus laevis embryos by translation initiation factor 4E.
    Science. 1994 Aug 5;265(5173):803-6 PMID: 8047887
  24. Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members.
    Nucleic Acids Res. 1994 Jul 25;22(14):2801-10 PMID: 8052536
  25. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.
    EMBO J. 1994 Sep 1;13(17):4070-9 PMID: 8076602
  26. An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants.
    Mol Cell Biol. 1995 May;15(5):2527-35 PMID: 7739536
  27. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
  28. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  29. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.
    Nature. 1983 Aug 18-24;304(5927):596-602 PMID: 6308472
  30. Translocations among antibody genes in human cancer.
    Science. 1983 Nov 18;222(4625):765-71 PMID: 6356357
  31. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.
    Cell. 1983 Dec;35(3 Pt 2):603-10 PMID: 6606489
  32. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.
    Cell. 1984 Oct;38(3):627-37 PMID: 6488314
  33. Regulation of initiation factors during translational repression caused by serum depletion. Abundance, synthesis, and turnover rates.
    J Biol Chem. 1985 May 10;260(9):5486-92 PMID: 3988764
  34. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
    Nature. 1985 Dec 12-18;318(6046):533-8 PMID: 3906410
  35. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region.
    Cell. 1985 Nov;43(1):165-75 PMID: 4075392
  36. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.
    Nucleic Acids Res. 1987 Jul 10;15(13):5490 PMID: 3037497
  37. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Nature. 1987 Jul 30-Aug 5;328(6129):445-9 PMID: 3302722
  38. Activation and repression of mammalian gene expression by the c-myc protein.
    Genes Dev. 1987 Jun;1(4):347-57 PMID: 3678827
  39. Gel retardation at low pH resolves trp repressor-DNA complexes for quantitative study.
    Proc Natl Acad Sci U S A. 1988 Feb;85(4):975-9 PMID: 3277190
  40. Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF.
    J Biol Chem. 1988 Aug 25;263(24):11994-2001 PMID: 3403559
  41. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.
    Proc Natl Acad Sci U S A. 1988 Aug;85(16):6047-51 PMID: 3261863
  42. CDC33 encodes mRNA cap-binding protein eIF-4E of Saccharomyces cerevisiae.
    Mol Cell Biol. 1988 Aug;8(8):3556-9 PMID: 3062383
  43. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.
    Cell. 1989 Mar 10;56(5):777-83 PMID: 2493990
  44. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo.
    Genes Dev. 1989 Jun;3(6):860-9 PMID: 2663644
  45. G1 events and regulation of cell proliferation.
    Science. 1989 Nov 3;246(4930):603-8 PMID: 2683075
  46. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif.
    Genes Dev. 1990 Feb;4(2):167-79 PMID: 2338243
  47. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.
    Nature. 1990 Jun 7;345(6275):544-7 PMID: 2348862
  48. Are myc proteins transcription factors?
    Cancer Cells. 1990 Mar;2(3):69-75 PMID: 2202379
  49. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F.
    J Biol Chem. 1987 Jan 5;262(1):380-8 PMID: 3793730
  50. Amino acid sequence of the mRNA cap-binding protein from human tissues.
    Proc Natl Acad Sci U S A. 1987 Feb;84(4):945-9 PMID: 3469651
  51. Definition of regions in human c-myc that are involved in transformation and nuclear localization.
    Mol Cell Biol. 1987 May;7(5):1697-709 PMID: 3299053
  52. Translational control in mammalian cells.
    Annu Rev Biochem. 1991;60:717-55 PMID: 1883206
  53. Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistinguishable from that of natural 43/44-kDa USF.
    Mol Cell Biol. 1991 Oct;11(10):5125-36 PMID: 1922036
  54. Transgenic models of tumor development.
    Science. 1991 Nov 22;254(5035):1161-7 PMID: 1957168
  55. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF.
    Nature. 1991 Nov 21;354(6350):245-8 PMID: 1961251
  56. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family.
    Genes Dev. 1991 Dec;5(12A):2342-52 PMID: 1748288
  57. c-myc oncoprotein function.
    Biochim Biophys Acta. 1991 Dec 10;1072(2-3):103-13 PMID: 1751543
  58. Myc and Max associate in vivo.
    Genes Dev. 1992 Jan;6(1):71-80 PMID: 1730411
  59. Max: functional domains and interaction with c-Myc.
    Genes Dev. 1992 Jan;6(1):81-92 PMID: 1730412
  60. Max and c-Myc/Max DNA-binding activities in cell extracts.
    Oncogene. 1992 Sep;7(9):1783-92 PMID: 1501888
  61. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Science. 1991 Mar 8;251(4998):1211-7 PMID: 2006410
  62. N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma.
    EMBO J. 1991 May;10(5):1119-25 PMID: 1902412
  63. Control of c-myc regulation in normal and neoplastic cells.
    Adv Cancer Res. 1991;56:1-48 PMID: 2028839
  64. Multiple mRNAs encode the murine translation initiation factor eIF-4E.
    J Biol Chem. 1991 Jun 5;266(16):10446-51 PMID: 2037592
  65. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.
    Mol Cell Biol. 1991 Jul;11(7):3699-710 PMID: 2046673
  66. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.
    Genes Dev. 1993 Apr;7(4):671-82 PMID: 8458579
  67. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
    Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2935-9 PMID: 8385351
  68. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6175-8 PMID: 8327497
  69. Binding of myc proteins to canonical and noncanonical DNA sequences.
    Mol Cell Biol. 1993 Sep;13(9):5216-24 PMID: 8395000
  70. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8 PMID: 8356088
  71. Direct role for Myc in transcription initiation mediated by interactions with TFII-I.
    Nature. 1993 Sep 23;365(6444):359-61 PMID: 8377829
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1996-09-00
Pages
4754-64
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC231476
Subset
IM
Grants
NCI NIH HHS · R01-CA63117 · United States
NINDS NIH HHS · T32NS07340-04 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com